Liquid biopsy is a non-invasive technique that offers a window into the body's molecular secrets, using just a simple blood draw or urine sample. Accessing ccfDNA from these biopsies is opening up powerful possibilities for disease detection and management.
Now with optimized workflows for cell-free DNA (ccfDNA) isolation, the QIAsymphony SP platform can now meet the changing needs of varying workloads and different sample types, processing a variety of large volumes using kits specifically developed for low-abundance targets.
The QIAsymphony DSP Circulating DNA Kits are intended for in vitro diagnostic use.
The QIAsymphony SP and AS instruments are intended for use by professional users, such as technicians and physicians trained in molecular biological techniques and the operation of QIAsymphony SP and AS instruments. The QIAsymphony SP instrument is designed to perform automated purification of nucleic acids in molecular diagnostic and/or molecular biology applications. It is intended to be used only in combination with QIAsymphony Kits indicated for use with the QIAsymphony SP for the applications described in the kit handbooks. The QIAsymphony AS instrument is designed to perform automated assay setup in molecular diagnostic and/or molecular biology applications. If used in combination with QIAGEN Kits indicated for use with the QIAsymphony AS instrument it is intended for the applications described in the respective QIAGEN Kit handbooks. If the QIAsymphony AS instrument is used with kits other than QIAGEN Kits, it is the user's responsibility to validate the performance of such product combination for any particular application.